Mechanism of Action CJC-1295 acts by binding to the GHRH receptor (GHRHR) expressed on the surface of somatotropic cells of the anterior pituitary
The principal study group experienced significant decreases in both liver fat and waist circumference, roughly 20% less on average
For example, if you started a GLP-1 in September 2024 with a BMI of 37, but in July 2026 you've lost weight and now have a BMI of 34, the prescriber should attest in the prior authorization request that you met the BMI criteria of 35 or over when the GLP-1 therapy started
Hashash JG, Thompson CC, Wang AY
In a prospective study of T2DM patients, six months of liraglutide therapy improved diastolic function and reduced left ventricular mass index [44], while additional echocardiographic studies have reported improvements in global longitudinal strain and left ventricular mass with GLP-1 receptor agonists [45]
Lagrange, A